Regarding potential value of the Makira rainforest area through the lens of commercial pharmaceutical development, based on a calculation of 1 to 18 potentially novel drugs derived from ethnomedicines used in the area, and using current average sales value of novel FDA-approved pharmaceuticals, the author estimated that the protected area “could hold between $316 million to almost $6 billion of untapped revenue within its botanical diversity.”
Considering the potential pharmaceutical value of the Makira rainforest through ethnomedicines and current average sales values for new FDA-approved medications, the author estimated that the protected area “could contain between $316 million to almost $6 billion worth of untapped revenue due to its botanical diversity.”